News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
839,413 Results
Type
Article (86133)
Company Profile (649)
Press Release (752631)
Multimedia
Podcasts (129)
Webinars (14)
Section
Business (232238)
Career Advice (4125)
Deals (39712)
Drug Delivery (126)
Drug Development (90803)
Employer Resources (198)
FDA (18004)
Job Trends (17327)
News (395597)
Policy (39679)
Tag
Academia (2992)
Academic (1)
Accelerated approval (6)
Adcomms (25)
Allergies (81)
Alliances (56671)
ALS (81)
Alzheimer's disease (1473)
Antibody-drug conjugate (ADC) (143)
Approvals (17991)
Artificial intelligence (227)
Autoimmune disease (27)
Automation (12)
Bankruptcy (402)
Best Places to Work (12512)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (447)
Bladder cancer (77)
Brain cancer (26)
Breast cancer (231)
Cancer (2050)
Cardiovascular disease (142)
Career advice (3532)
Career pathing (34)
CAR-T (162)
Cell therapy (451)
Cervical cancer (17)
Clinical research (72862)
Collaboration (791)
Company closure (1)
Compensation (454)
Complete response letters (28)
COVID-19 (2833)
CRISPR (44)
C-suite (226)
Cystic fibrosis (99)
Data (1891)
Decentralized trials (2)
Denatured (45)
Depression (39)
Diabetes (188)
Diagnostics (6766)
Digital health (10)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (118)
Drug pricing (96)
Drug shortages (17)
Duchenne muscular dystrophy (82)
Earnings (95441)
Editorial (38)
Employer branding (25)
Employer resources (167)
Events (128641)
Executive appointments (624)
FDA (18976)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (652)
Gene editing (101)
Generative AI (22)
Gene therapy (321)
GLP-1 (736)
Government (5112)
Grass and pollen (4)
Guidances (48)
Healthcare (20747)
Huntington's disease (25)
IgA nephropathy (29)
Immunology and inflammation (129)
Indications (25)
Infectious disease (2956)
Inflammatory bowel disease (151)
Inflation Reduction Act (11)
Influenza (50)
Intellectual property (86)
Interviews (812)
IPO (17695)
IRA (38)
Job creations (5186)
Job search strategy (2861)
Kidney cancer (11)
Labor market (41)
Layoffs (545)
Leadership (22)
Legal (10057)
Liver cancer (72)
Lung cancer (294)
Lymphoma (139)
Machine learning (6)
Management (65)
Manufacturing (292)
MASH (70)
Medical device (14304)
Medtech (14309)
Mergers & acquisitions (22287)
Metabolic disorders (598)
Multiple sclerosis (78)
NASH (22)
Neurodegenerative disease (103)
Neuropsychiatric disorders (23)
Neuroscience (1981)
NextGen: Class of 2025 (7666)
Non-profit (5060)
Now hiring (40)
Obesity (320)
Opinion (272)
Ovarian cancer (69)
Pain (70)
Pancreatic cancer (64)
Parkinson's disease (134)
Partnered (19)
Patents (197)
Patient recruitment (96)
Peanut (48)
People (64925)
Pharmaceutical (131)
Pharmacy benefit managers (13)
Phase I (22518)
Phase II (31681)
Phase III (23812)
Pipeline (1052)
Policy (144)
Postmarket research (3542)
Preclinical (10153)
Press Release (72)
Prostate cancer (90)
Psychedelics (34)
Radiopharmaceuticals (251)
Rare diseases (363)
Real estate (7384)
Recruiting (75)
Regulatory (26456)
Reports (55)
Research institute (2647)
Resumes & cover letters (649)
Rett syndrome (2)
RNA editing (5)
RSV (35)
Schizophrenia (71)
Series A (127)
Series B (72)
Service/supplier (25)
Sickle cell disease (46)
Special edition (18)
Spinal muscular atrophy (165)
Sponsored (34)
Startups (4286)
State (2)
Stomach cancer (11)
Supply chain (51)
Tariffs (38)
The Weekly (82)
Vaccines (738)
Venture capitalists (41)
Weight loss (228)
Women's health (37)
Worklife (20)
Date
Today (123)
Last 7 days (767)
Last 30 days (2182)
Last 365 days (28890)
2025 (9007)
2024 (34084)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Alabama (54)
Alaska (6)
Arizona (246)
Arkansas (8)
Asia (49861)
Australia (8797)
California (5389)
Canada (1602)
China (501)
Colorado (167)
Connecticut (228)
Delaware (133)
Europe (114128)
Florida (676)
Georgia (147)
Hawaii (1)
Idaho (64)
Illinois (449)
India (25)
Indiana (272)
Iowa (10)
Japan (138)
Kansas (111)
Kentucky (16)
Louisiana (8)
Maine (58)
Maryland (857)
Massachusetts (4241)
Michigan (190)
Minnesota (311)
Mississippi (1)
Missouri (53)
Montana (24)
Nebraska (26)
Nevada (55)
New Hampshire (50)
New Jersey (1534)
New Mexico (27)
New York (1527)
North Carolina (1014)
North Dakota (8)
Northern California (2358)
Ohio (163)
Oklahoma (13)
Oregon (45)
Pennsylvania (1144)
Puerto Rico (12)
Rhode Island (24)
South America (1648)
South Carolina (5)
South Dakota (1)
Southern California (2015)
Tennessee (32)
Texas (705)
United States (20211)
Utah (115)
Virginia (105)
Washington D.C. (39)
Washington State (532)
West Virginia (1)
Wisconsin (41)
839,413 Results for "bird rock bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Vaccines
Moderna Nabs Another $590M from HHS for mRNA-Based Bird Flu Vaccines
The funding, which follows the $176 million the government awarded Moderna in June 2024, aims to get mRNA vaccines ready before bird flu strains currently circulating in the wild and on farms can potentially cause human outbreaks.
January 21, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Bioxytran Signs NDA with the University of Georgia to Evaluate Galectin Antagonists for Bird Flu Treatment in Chickens
March 19, 2025
·
2 min read
Press Releases
Magnet-Like Nanoparticle Vaccine Achieves 100% Protection Against H5N1 (Bird Flu) in Preclinical Trials
April 18, 2025
·
2 min read
Neurodegenerative disease
Scholar Rock’s Shares Soar 300% After Phase III Win in Spinal Muscular Atrophy
With Monday’s data from SAPPHIRE, Scholar Rock is building toward regulatory submissions for apitegromab in spinal muscular atrophy in the first quarter of 2025.
October 8, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Traws Pharma’s Bird Flu Drug Candidate, Tivoxavir Marboxil, Presented at ICAR
March 24, 2025
·
6 min read
Press Releases
Scholar Rock Appoints David L. Hallal as Chief Executive Officer; Also Announces Addition of Three Key Leaders to Scale for Next Phase of Growth
April 28, 2025
·
9 min read
Neuroscience
GSK Dives Deeper Into Neuro With $2.5B+ ABL Bio Pact
GSK is paying to access ABL Bio’s Grabody-B platform, which potentially enables therapies to cross the blood-brain barrier.
April 7, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Scholar Rock to Participate in Upcoming March 2025 Investor Conferences
February 26, 2025
·
2 min read
Press Releases
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 18, 2025
April 21, 2025
·
3 min read
Press Releases
Scholar Rock Reports Full Year 2024 Financial Results and Highlights Business Progress
February 27, 2025
·
18 min read
1 of 83,942
Next
